Evidence map›Paper›PMID 32102251›Full record

ArticlePharmaceutics2020

Effect of Oxaliplatin-Loaded Poly (d,l-Lactide-

Ana Luiza C de S L Oliveira, Raimundo Fernandes de Araújo Júnior, Thaís Gomes de Carvalho, Alan B Chan, Timo Schomann, Filippo Tamburini, Lioe-Fee de Geus-Oei, Luis J Cruz

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceutics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.3field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 39 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Nanoparticles Loaded with Platinum Drugs for Colorectal Cancer Therapy.International journal of molecular sciences · 2022
    Review
  5. Review
  6. Retinoids as anti-cancer agents and their mechanisms of action.American journal of cancer research · 2022
    Review
  7. Nanomedicines in the treatment of colon cancer: a focus on metallodrugs.Drug delivery and translational research · 2022
    Review
  8. Review
  9. Retinoic Acid-Loaded Poly(lactic-Journal of biomedical nanotechnology · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Ana Luiza C de S L OliveiraPostgraduate Program in Health Science, Federal University of Rio Grande do Norte (UFRN), 59078 970 Natal, RN, Brazil.
Raimundo Fernandes de Araújo JúniorPostgraduate Program in Health Science, Federal University of Rio Grande do Norte (UFRN), 59078 970 Natal, RN, Brazil.ORCID 0000-0003-2349-2354
Thaís Gomes de CarvalhoPostgraduate Program in Health Science, Federal University of Rio Grande do Norte (UFRN), 59078 970 Natal, RN, Brazil.ORCID 0000-0002-1317-8890
Alan B ChanPercuros B.V, Zernikedreef 8, 2333 CL Leiden, The Netherlands.
Timo SchomannTranslational Nanobiomaterials and Imaging, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.ORCID 0000-0002-0948-6209
Filippo TamburiniPercuros B.V, Zernikedreef 8, 2333 CL Leiden, The Netherlands.ORCID 0000-0001-5991-6871
Lioe-Fee de Geus-OeiNuclear Medicine, Department of Radiology, Leiden University Medical Center, 2333 ZA Leiden, The Netherlands.
Luis J CruzTranslational Nanobiomaterials and Imaging, Department of Radiology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
Leiden University Medical Center · NLPercuros (Netherlands) · NL

Funding

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88881.119850/2016-01Coordenação de Aperfeiçoamento de Pessoal de Nível Superior 88881.133518/2016-01Horizon 2020 Framework Programme 644373Horizon 2020 Framework Programme 734684Horizon 2020 Framework Programme 777682Nederlandse Organisatie voor Wetenschappelijk Onderzoek 723.012.110
6 · The paper itself

Abstract

Apoptosis signaling pathways, drug resistance, and metastasis are important targets to develop new cancer treatments. We developed cholesterol-coated Poly(d,l-Lactide-

Indexed as

apoptosiscolorectal cancerdrug resistanceoxaliplatinPLGA nanoparticles

Identifiers

PMID32102251
PMCPMC7076533
OpenAlexW3006785324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.